Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

63.98
Delayed Data
As of Aug 28
 -0.53 / -0.82%
Today’s Change
52.06
Today|||52-Week Range
71.60
-2.23%
Year-to-Date

Today’s Trading

Previous close64.51
Today’s open63.91
Day’s range63.44 - 64.78
Volume7,316,411
Average volume (3 months)9,360,557
Market cap$105.9B
Dividend yield3.19%
Data as of 4:04pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-57.03%
Earnings growth (this year)+28.25%
Earnings growth (next 5 years)+14.10%
Revenue growth (last year)+6.23%
P/E ratio49.6
Price/Sales5.28
Price/Book58.45

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb-0.21-0.35%
GSKGlaxoSmithKline+0.04+0.10%
NVONovo Nordisk-0.43-0.77%
CELGCelgene+1.00+0.81%
Data as of 4:03pm ET, 08/28/2015

Financials

Next reporting dateOctober 30, 2015
EPS forecast (this quarter)$1.06
Annual revenue (last year)$20.0B
Annual profit (last year)$1.8B
Net profit margin8.89%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts

Partner Offers